People: Novartis AG (NOVN.VX)
5 Dec 2013
Dr. Wendelin Wiedeking has been Member of the Board of Directors at Novartis AG since 2003. He qualifies as an independent Non-Executive Director. He is Member of the Audit and Compliance Committee and the Risk Committee of the Company. Dr. Wiedeking was Chairman of the Executive Board of Porsche Automobil Holding SE and of Dr. Ing. h.c. F. Porsche AG, both in Germany until July 2009. Since then he has been an entrepreneur. His professional career began in 1983 in Germany as Director’s Assistant in the Production and Materials Management area of Dr. Ing. h.c. F. Porsche AG in Stuttgart-Zuffenhausen. In 1988, he moved to Glyco Metall-Werke KG in Wiesbaden as Division Manager, where he advanced by 1990 to the position of Chief Executive Officer and Chairman of the Board of Management of Glyco AG. In 1991, he returned to Dr. Ing. h.c. F. Porsche AG as Production Director. A year later, the Supervisory Board appointed him Spokesman of the Executive Board (CEO), and Chairman in 1993. Dr. Wiedeking graduated in mechanical engineering in 1978 and worked as a scientific assistant in the Machine Tool Laboratory of the Rhine-Westphalian College of Advanced Technology in Germany.
|Total Annual Compensation, CHF||Long-Term Incentive Plans, CHF||All Other, CHF||Fiscal Year Total, CHF|